| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439301 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
These EAP results suggest that elderly patients with advanced squamous NSCLC benefit from nivolumab, with tolerability similar to that in the overall population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Francesco Grossi, Lucio Crinò, Antonio Logroscino, Stefania Canova, Angelo Delmonte, Barbara Melotti, Claudia Proto, Alain Gelibter, Federico Cappuzzo, Daniele Turci, Teresa Gamucci, Paola Antonelli, Paolo Marchetti, Armando Santoro, Sabrina Giusti,